tirzepatide surmount-1 trial weight loss non-diabetic Effect of in trial. (BMI: body mass index; CI: Weight reduction with different doses

For background on the compounding landscape, see is compound tirzepatide safe and compound semaglutide with B12

Used textbooks may not include companion materials such as access codes, etc

These medications can slow the passage of food through the stomach, which can lead to serious digestive problems such as stomach paralysis, pancreatitis and bowel obstructions

Include gradual dose reduction, continued dietary modifications, regular exercise, behavioral support, and potentially transitioning to alternative weight management strategies

Soluble fiber is recommended by the International Foundation for Gastrointestinal Disorders as a bulking agent to reduce watery stool